Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study
- PMID: 8720611
- DOI: 10.1007/BF00400421
Fasting proinsulin and 2-h post-load glucose levels predict the conversion to NIDDM in subjects with impaired glucose tolerance: the Hoorn Study
Abstract
The aims of the present study were to observe the natural history of impaired glucose tolerance and to identify predictors for development of non-insulin-dependent diabetes mellitus (NIDDM). A survey of glucose tolerance was conducted in subjects aged 50-74 years, randomly selected from the registry of the middle-sized town of Hoorn in the Netherlands. Based on the mean values of two oral glucose tolerance tests subjects were classified in categories of glucose tolerance according to the World Health Organization criteria. All subjects with impaired glucose tolerance (n = 224) were invited to participate in the present study, in which 70% (n = 158) were subsequently enrolled. During follow-up subjects underwent a repeated paired oral glucose tolerance test. The mean follow-up time was 24 months (range 12-36 months). The cumulative incidence of NIDDM was 28.5% (95% confidence interval 15-42%). Age, sex, and anthropometric and metabolic characteristics at baseline were analysed simultaneously as potential predictors of conversion to NIDDM using multiple logistic regression. The initial 2-h post-load plasma glucose levels and the fasting proinsulin levels were significantly (p < 0.05) related to the incidence of NIDDM. Anthropometric characteristics, the 2-h post-load specific insulin levels and the fasting proinsulin/fasting insulin ratio were not related to the incidence of NIDDM. These results suggest that beta-cell dysfunction rather than insulin resistance plays the most important role in the future development of diabetes in a high-risk Caucasian population.
Similar articles
-
Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study.J Clin Epidemiol. 1997 Sep;50(9):1003-9. doi: 10.1016/s0895-4356(97)00119-4. J Clin Epidemiol. 1997. PMID: 9363034
-
Proinsulin levels predict the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japanese-American men.Diabet Med. 1996 Sep;13(9 Suppl 6):S63-6. Diabet Med. 1996. PMID: 8894485
-
Total immunoreactive proinsulin, immunoreactive insulin and specific insulin in relation to conversion to NIDDM: the Mexico City Diabetes Study.Diabetologia. 1997 Jul;40(7):830-7. doi: 10.1007/s001250050756. Diabetologia. 1997. PMID: 9243105
-
Determinants for the progression from impaired glucose tolerance to non-insulin-dependent diabetes mellitus.Eur J Clin Invest. 1998 Sep;28 Suppl 2:8-13. doi: 10.1046/j.1365-2362.1998.0280s2008.x. Eur J Clin Invest. 1998. PMID: 9777321 Review.
-
Circulating proinsulin-like molecules.J Diabetes Complications. 1993 Apr-Jun;7(2):113-23. doi: 10.1016/1056-8727(93)90036-x. J Diabetes Complications. 1993. PMID: 8518453 Review.
Cited by
-
DC260126: a small-molecule antagonist of GPR40 that protects against pancreatic β-Cells dysfunction in db/db mice.PLoS One. 2013 Jun 11;8(6):e66744. doi: 10.1371/journal.pone.0066744. Print 2013. PLoS One. 2013. PMID: 23776696 Free PMC article.
-
The abnormalities of carbohydrate metabolism in Turner syndrome: analysis of risk factors associated with impaired glucose tolerance.Eur J Pediatr. 2005 Jul;164(7):442-7. doi: 10.1007/s00431-005-1643-x. Epub 2005 Apr 23. Eur J Pediatr. 2005. PMID: 15856295
-
Prominent Hyperproinsulinemia in a Middle Age Patient.Clin Med Insights Case Rep. 2021 Sep 1;14:11795476211042241. doi: 10.1177/11795476211042241. eCollection 2021. Clin Med Insights Case Rep. 2021. PMID: 34483693 Free PMC article.
-
Proinsulin and acute insulin response independently predict Type 2 diabetes mellitus in men--report from 27 years of follow-up study.Diabetologia. 2003 Jan;46(1):20-6. doi: 10.1007/s00125-002-0995-2. Epub 2003 Jan 8. Diabetologia. 2003. PMID: 12637978
-
Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia.Cochrane Database Syst Rev. 2018 Oct 29;10(10):CD012661. doi: 10.1002/14651858.CD012661.pub2. Cochrane Database Syst Rev. 2018. PMID: 30371961 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical